Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Berberine Hydrochloride, Amoxicillin and Rabeprazole Triple Therapy in the First Eradication of Helicobacter Pylori

NCT04697186 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT04697186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04697186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Berberine Hydrochloride, Amoxicillin and Rabeprazole Triple Therapy in the First Eradication of Helicobacter Pylori
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Completed
Start date
January 7, 2021
Completion date
December 20, 2021
Enrollment
524 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic gastritis, dyspepsia, gastric cancer, helicobacter pylori infection